Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Benefit of STent Placement and Blood Pressure and Lipid-Lowering for the Prevention of Progression of Renal Dysfunction Caused by Atherosclerotic Ostial Stenosis of the Renal Artery (STAR)

NCT00150943 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00150943
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150943 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Benefit of STent Placement and Blood Pressure and Lipid-Lowering for the Prevention of Progression of Renal Dysfunction Caused by Atherosclerotic Ostial Stenosis of the Renal Artery (STAR)
Lead sponsor
UMC Utrecht
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
Not reported
Enrollment
140
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney failure, renal artery obstruction